Date Filed | Type | Description |
03/13/2023 |
4
| Pascoe Richard W (CEO) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.
Txns:
| Bought 10,000 shares
@ $4.1978, valued at
$42k
|
|
01/13/2023 |
4
| Pascoe Richard W (CEO) has filed a Form 4 on KEMPHARM, INC
Txns:
| Bought 9,500 shares
@ $5.4399, valued at
$51.7k
|
|
01/11/2023 |
4
| Pascoe Richard W (CEO) has filed a Form 4 on KEMPHARM, INC
Txns:
| Granted 700,000 options to buy
@ $4.54, valued at
$3.2M
|
|
01/05/2023 |
4
| Pascoe Richard W (Director) has filed a Form 4 on SEELOS THERAPEUTICS, INC.
Txns:
| Granted 50,000 options to buy
@ $0.81, valued at
$40.5k
|
|
05/18/2022 |
4
| Pascoe Richard W (Executive Chairman) has filed a Form 4 on KEMPHARM, INC
Txns:
| Bought 300 shares
@ $4.8999, valued at
$1.5k
Bought 100 shares
@ $4.9, valued at
$490 Bought 400 shares
@ $4.9099, valued at
$2k
Bought 400 shares
@ $4.91, valued at
$2k
Bought 1,767 shares
@ $4.92, valued at
$8.7k
Bought 1,700 shares
@ $4.93, valued at
$8.4k
Bought 333 shares
@ $4.94, valued at
$1.6k
|
|
02/03/2022 |
4
| Pascoe Richard W (Executive Chairman) has filed a Form 4 on KEMPHARM, INC
Txns:
| Granted 127,286 options to buy
@ $7.17, valued at
$912.6k
|
|
01/06/2022 |
4
| Pascoe Richard W (Director) has filed a Form 4 on SEELOS THERAPEUTICS, INC.
Txns:
| Granted 35,000 options to buy
@ $1.56, valued at
$54.6k
|
|
11/30/2021 |
4
| Pascoe Richard W (Executive Chairman) has filed a Form 4 on KEMPHARM, INC
Txns:
| Bought 1,500 shares
@ $7.8814, valued at
$11.8k
|
|
11/10/2021 |
4
| Pascoe Richard W (Executive Chairman) has filed a Form 4 on KEMPHARM, INC
Txns:
| Granted 100,000 options to buy
@ $9.1, valued at
$910k
|
|
06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/07/2020 |
4
| Pascoe Richard W (President, CEO & Director) has filed a Form 4 on Histogen Inc.
Txns:
| Bought 10,000 shares
@ $1.2394, valued at
$12.4k
|
|
08/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/28/2020 |
4
| Pascoe Richard W (See Remarks) has filed a Form 4 on Histogen Inc.
Txns:
| Acquired 291,107 options to buy
@ $5.3, valued at
$1.5M
Acquired 194,071 options to buy
@ $5.3, valued at
$1M
|
|
05/28/2020 |
3
| Pascoe Richard W (See Remarks) has filed a Form 3 on Histogen Inc. |
01/07/2020 |
4
| Pascoe Richard W (Director) has filed a Form 4 on SEELOS THERAPEUTICS, INC.
Txns:
| Granted 16,000 options to buy
@ $1.42, valued at
$22.7k
|
|
07/02/2019 |
4
| Pascoe Richard W (Director) has filed a Form 4 on KEMPHARM, INC
Txns:
| Granted 8,928 shares
@ $0 |
|
05/14/2019 |
4
| Pascoe Richard W (Director) has filed a Form 4 on KEMPHARM, INC
Txns:
| Granted 9,645 shares
@ $0 |
|
04/26/2019 |
4
| Pascoe Richard W (Director) has filed a Form 4 on KEMPHARM, INC
Txns:
| Granted 30,000 options to buy
@ $0 |
|
03/21/2019 |
4
| Pascoe Richard W (Director) has filed a Form 4 on SEELOS THERAPEUTICS, INC.
Txns:
| Granted 16,000 options to buy
@ $2.33, valued at
$37.3k
|
|
01/24/2019 |
4
| Pascoe Richard W (CEO & Secretary) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns:
| Paid exercise price by delivering 44,810 shares
@ $0.2265, valued at
$10.1k
|
|
11/30/2018 |
4
| Pascoe Richard W (CEO & Secretary) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns:
| Paid exercise price by delivering 17,290 shares
@ $0.306, valued at
$5.3k
|
|
05/24/2018 |
4
| Pascoe Richard W (Director) has filed a Form 4 on KEMPHARM, INC
Txns:
| Granted 15,000 options to buy
@ $0 |
|
01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/24/2017 |
4
| Pascoe Richard W (Director) has filed a Form 4 on KEMPHARM, INC
Txns:
| Granted 10,000 options to buy
@ $0 |
|
03/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/26/2016 |
4
| Pascoe Richard W (Director) has filed a Form 4 on KEMPHARM, INC
Txns:
| Granted 10,000 options to buy
@ $0 |
|
04/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|